Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

A shadow falls over gene patents in the United States and Europe

Nature Biotechnology volume 28, pages 1172–1173 (2010)Cite this article

Subjects

Will a pair of court decisions that restrict the protection offered to DNA-based claims reduce financial incentives and thus chill investment?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Case 428/08 Monsanto Technology LLC v. Cefetra BV & Others.

  2. Directive 98/44/EC, OJ 1998 L 213, 13.

  3. Association for Molecular Pathology et al. No. 09 Civ. 4515(S.D.N.Y.).

  4. Monsanto Technology LLC v. Cefetra BV & Others, 249983/HA ZA 05-2885 (Hague District Court 2008).

  5. European patent EP 0 546 090 Barry, G.F., Kishore, G.M. & Padgette, S.R., filed 28 August 1991.

  6. European Patent Convention, as given effect in the recent case of Eli Lilly v. HGS[2010] EWCA Civ 33.

  7. Paragraphs 70-77 of the Court's ruling in case 428/08, Monsanto Technology LLC v. Cefetra BV & Others.

  8. Monsanto Technology LLC v. Cargill parties, EWHC 2257 (Pat), (10 October 2007).

  9. Cohen, S. & Morgan, G. Nat. Biotechnol. 26, 289–291 (2008).

    Article  CAS  Google Scholar 

  10. See last sentence of paragraph 36 of the Advocate General's opinion in case 428/08, Monsanto Technology LLC v. Cefetra BV & Others.

  11. Anonymous, Nature 465, 267–268 (2010).

    Google Scholar 

  12. Morgan, G. More patent protection for medicines with a new purpose, Nature 465, 1005 (2010).

    Article  CAS  Google Scholar 

  13. Diamond v. Chakrabarty, 447 US 303 (1980).

Download references

Author information

Authors and Affiliations

  1. Gareth Morgan and Lisa A. Haile are at DLA Piper LLP, London, UK.,

    Gareth Morgan & Lisa A. Haile

Authors
  1. Gareth Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa A. Haile
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gareth Morgan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, G., Haile, L. A shadow falls over gene patents in the United States and Europe. Nat Biotechnol 28, 1172–1173 (2010). https://doi.org/10.1038/nbt1110-1172

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1110-1172

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research